Wilson Therapeutics Company
Wilson Therapeutics focuses on developing novel therapies addressing unmet medical needs in rare diseases.
Industry:
PharmTech
Technology:
Cancer
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Investors Number:
2
Headquarters:
Stockholm, Stockholms Lan, Sweden
Employee Number:
11-50
Investor Type:
For Profit
Total Funding:
$27.2M
Founded Date:
2012
Last Funding Type:
Venture - Series Unknown